Globe Editorial
YESTERDAY'S HEARING in Washington on the diabetes drug Avandia and its links to heart attacks underscores the need for a reformed Food and Drug Administration -- one that is more committed to protecting patients than to being part of the profit pipeline of the pharmaceutical industry. Avandia is just the latest example of an FDA-approved drug or medical device that ... (Full article: 447 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
